The DOI matches its Crossref record; 332 of the 332 references it cites were found in a registry or an index.
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
Open accessAbstract
Duchenne muscular dystrophy (DMD) is a progressive muscle-wasting disorder. It is caused by loss-of-function mutations in the dystrophin gene. Currently, there is no cure. A highly promising therapeutic strategy is to replace or repair the defective dystrophin gene by gene therapy. Numerous animal models of DMD have been developed over the last 30 years, ranging from invertebrate to large mammalian models. mdx mice are the most commonly employed models in DMD research and have been used to lay the groundwork for DMD gene therapy. After ~30 years of development, the field has reached the stage at which the results in mdx mice can be validated and scaled-up in symptomatic large animals. The canine DMD (cDMD) model will be excellent for these studies. In this article, we review the animal models for DMD, the pros and cons of each model system, and the history and progress of preclinical DMD gene therapy research in the animal models. We also discuss the current and emerging challenges in this field and ways to address these challenges using animal models, in particular cDMD dogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693 · cited 4×
“A major function of dystrophin is to strengthen the sarcolemma by cross-linking the ECM with the cytoskeleton.”
BackgroundInfluentialRegulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90504-6 · Cited by 2,411
X chromosome-linked muscular dystrophy (mdx) in the mouse
Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765
Dystrophin protects the sarcolemma from stresses developed during muscle contraction
Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., & Sweeney, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3710 · Cited by 1,526
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Population frequencies of inherited neuromuscular diseases—A world survey
Emery, A. E. H. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90039-u · Cited by 1,448
The Molecular Basis of Muscular Dystrophy in the mdx Mouse: a Point Mutation
Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G., & Barnard, P. J. (1989) · Science · doi:10.1126/science.2662404 · Cited by 1,276
Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle
Blake, D. J., Weir, A., Newey, S. E., & Davies, K. E. (2002) · Physiological Reviews · doi:10.1152/physrev.00028.2001 · Cited by 1,242
Monaco, A. P., Bertelson, C. J., Liechti-Gallati, S., Moser, H., & Kunkel, L. M. (1988) · Genomics · doi:10.1016/0888-7543(88)90113-9 · Cited by 1,210
McDonald, C. M., Abresch, R. T., Carter, G. T., Fowler, W. M., Johnson, E. R., Kilmer, D. D., & Sigford, B. J. (1995) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-199509001-00003 · Cited by 1,069
Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene
Monaco, A. P., Neve, R. L., Colletti-Feener, C., Bertelson, C. J., Kurnit, D. M., & Kunkel, L. M. (1986) · Nature · doi:10.1038/323646a0 · Cited by 1,067
The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy
Stedman, H. H., Sweeney, H. L., Shrager, J. B., Maguire, H. C., Panettieri, R. A., Petrof, B., Narusawa, M., Leferovich, J. M., Sladky, J. T., & Kelly, A. M. (1991) · Nature · doi:10.1038/352536a0 · Cited by 926
Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M. E., Bourke, J., Wells, D. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60756-3 · Cited by 878
REGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819
Eteplirsen for the treatment of Duchenne muscular dystrophy
Mendell, J. R., Rodino‐Klapac, L. R., Sahenk, Z., Roush, K., Bird, L., Lowes, L. P., Alfano, L., Gomez, A. M., Lewis, S., Kota, J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23982 · Cited by 817
Local Dystrophin Restoration with Antisense Oligonucleotide PRO051
van Deutekom, J. C., Janson, A. A., Ginjaar, I. B., Frankhuizen, W. S., Aartsma-Rus, A., Bremmer-Bout, M., den Dunnen, J. T., Koop, K., van der Kooi, A. J., Goemans, N. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073108 · Cited by 781
Contractile properties of skeletal muscles from young, adult and aged mice.
Brooks, S. V., & Faulkner, J. A. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017279 · Cited by 777
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
Sampaolesi, M., Blot, S., D’Antona, G., Granger, N., Tonlorenzi, R., Innocenzi, A., Mognol, P., Thibaud, J.-L., Galvez, B. G., Barthélémy, I., et al. (2006) · Nature · doi:10.1038/nature05282 · Cited by 769
Utrophin–dystrophin-deficient mice as a model for Duchenne muscular dystrophy
Deconinck, A. E., Rafael, J. A., Skinner, J. A., Brown, S. C., Potter, A. C., Metzinger, L., Watt, D. J., Dickson, J. G., Tinsley, J. M., & Davies, K. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80532-2 · Cited by 752
Aartsma‐Rus, A., Van Deutekom, J. C. T., Fokkema, I. F., Van Ommen, G. B., & Den Dunnen, J. T. (2006) · Muscle & Nerve · doi:10.1002/mus.20586 · Cited by 739
MyoD is required for myogenic stem cell function in adult skeletal muscle
Megeney, L. A., Kablar, B., Garrett, K., Anderson, J. E., & Rudnicki, M. A. (1996) · Genes & Development · doi:10.1101/gad.10.10.1173 · Cited by 724
Prevention of muscular dystrophy in mice by CRISPR/Cas9–mediated editing of germline DNA
Long, C., McAnally, J. R., Shelton, J. M., Mireault, A. A., Bassel-Duby, R., & Olson, E. N. (2014) · Science · doi:10.1126/science.1254445 · Cited by 720
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Goemans, N. M., Tulinius, M., van den Akker, J. T., Burm, B. E., Ekhart, P. F., Heuvelmans, N., Holling, T., Janson, A. A., Platenburg, G. J., Sipkens, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011367 · Cited by 678
Kinali, M., Arechavala-Gomeza, V., Feng, L., Cirak, S., Hunt, D., Adkin, C., Guglieri, M., Ashton, E., Abbs, S., Nihoyannopoulos, P., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70211-x · Cited by 653
The structural and functional diversity of dystrophin
Ahn, A. H., & Kunkel, L. M. (1993) · Nature Genetics · doi:10.1038/ng0493-283 · Cited by 650
Grady, R. M., Teng, H., Nichol, M. C., Cunningham, J. C., Wilkinson, R. S., & Sanes, J. R. (1997) · Cell · doi:10.1016/s0092-8674(00)80533-4 · Cited by 643
Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface
Bonilla, E., Samitt, C. E., Miranda, A. F., Hays, A. P., Salviati, G., DiMauro, S., Kunkel, L. M., Hoffman, E. P., & Rowland, L. P. (1988) · Cell · doi:10.1016/0092-8674(88)90065-7 · Cited by 626
Very mild muscular dystrophy associated with the deletion of 46% of dystrophin
England, S. B., Nicholson, L. V. B., Johnson, M. A., Forrest, S. M., Love, D. R., Zubrzycka-Gaarn, E. E., Bulman, D. E., Harris, J. B., & Davies, K. E. (1990) · Nature · doi:10.1038/343180a0 · Cited by 623
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W., & Chamberlain, J. S. (2004) · Nature Medicine · doi:10.1038/nm1085 · Cited by 620
Expression of full-length utrophin prevents muscular dystrophy in mdx mice
Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J.-M., & Davies, K. (1998) · Nature Medicine · doi:10.1038/4033 · Cited by 615
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Wang, Z., Zhu, T., Qiao, C., Zhou, L., Wang, B., Zhang, J., Chen, C., Li, J., & Xiao, X. (2005) · Nature Biotechnology · doi:10.1038/nbt1073 · Cited by 608
Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy
Harper, S. Q., Hauser, M. A., DelloRusso, C., Duan, D., Crawford, R. W., Phelps, S. F., Harper, H. A., Robinson, A. S., Engelhardt, J. F., Brooks, S. V., et al. (2002) · Nature Medicine · doi:10.1038/nm0302-253 · Cited by 579
Self-citationKochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., & Caskey, C. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5731 · Cited by 562
Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice
Sacco, A., Mourkioti, F., Tran, R., Choi, J., Llewellyn, M., Kraft, P., Shkreli, M., Delp, S., Pomerantz, J. H., Artandi, S. E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.11.039 · Cited by 512
Wang, B., Li, J., & Xiao, X. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240335297 · Cited by 508
Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon Skipping
Goyenvalle, A., Vulin, A., Fougerousse, F., Leturcq, F., Kaplan, J.-C., Garcia, L., & Danos, O. (2004) · Science · doi:10.1126/science.1104297 · Cited by 506
Alter, J., Lou, F., Rabinowitz, A., Yin, H., Rosenfeld, J., Wilton, S. D., Partridge, T. A., & Lu, Q. L. (2006) · Nature Medicine · doi:10.1038/nm1345 · Cited by 494
Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene
Tinsley, J. M., Potter, A. C., Phelps, S. R., Fisher, R., Trickett, J. I., & Davies, K. E. (1996) · Nature · doi:10.1038/384349a0 · Cited by 490
Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs
Acsadi, G., Dickson, G., Love, D. R., Jani, A., Walsh, F. S., Gurusinghe, A., Wolff, J. A., & Davies, K. E. (1991) · Nature · doi:10.1038/352815a0 · Cited by 485
Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice
Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Coutont, D., Cartaud, J., Briand, P., Kaplant, J.-C., Perricaude, M., et al. (1993) · Nature · doi:10.1038/361647a0 · Cited by 457
Rutledge, E. A., Halbert, C. L., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.309-319.1998 · Cited by 452
The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs
Cooper, B. J., Winand, N. J., Stedman, H., Valentine, B. A., Hoffman, E. P., Kunkel, L. M., Scott, M.-O., Fischbeck, K. H., Kornegay, J. N., Avery, R. J., et al. (1988) · Nature · doi:10.1038/334154a0 · Cited by 428
Beggs, A. H., Hoffman, E. P., Snyder, J. R., Arahata, K., Specht, L. A., Shapiro, F., Angelini, C. I., Sugita, H., & Kunkel, L. M. (1991) · PubMed · Cited by 410
mdx mice show progressive weakness and muscle deterioration with age
Pastoret, C., & Sebille, A. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00276-t · Cited by 410
Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo
Pacak, C. A., Mah, C. S., Thattaliyath, B. D., Conlon, T. J., Lewis, M. A., Cloutier, D. E., Zolotukhin, I., Tarantal, A. F., & Byrne, B. J. (2006) · Circulation Research · doi:10.1161/01.res.0000237661.18885.f6 · Cited by 406
Lu, Q. L., Rabinowitz, A., Chen, Y. C., Yokota, T., Yin, H., Alter, J., Jadoon, A., Bou-Gharios, G., & Partridge, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406700102 · Cited by 402
Efficacy of systemic morpholino exon‐skipping in duchenne dystrophy dogs
Yokota, T., Lu, Q., Partridge, T., Kobayashi, M., Nakamura, A., Takeda, S., & Hoffman, E. (2009) · Annals of Neurology · doi:10.1002/ana.21627 · Cited by 398
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
Lu, Q. L., Mann, C. J., Lou, F., Bou-Gharios, G., Morris, G. E., Xue, S.-A., Fletcher, S., Partridge, T. A., & Wilton, S. D. (2003) · Nature Medicine · doi:10.1038/nm897 · Cited by 398
Lai, Y., Thomas, G. D., Yue, Y., Yang, H. T., Li, D., Long, C., Judge, L., Bostick, B., Chamberlain, J. S., Terjung, R. L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36612 · Cited by 389
Self-citationAntisense-induced exon skipping and synthesis of dystrophin in the mdx mouse
Mann, C. J., Honeyman, K., Cheng, A. J., Ly, T., Lloyd, F., Fletcher, S., Morgan, J. E., Partridge, T. A., & Wilton, S. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.42 · Cited by 388
Loss of myostatin attenuates severity of muscular dystrophy in mdx mice
Wagner, K. R., McPherron, A. C., Winik, N., & Lee, S. (2002) · Annals of Neurology · doi:10.1002/ana.10385 · Cited by 379
Tuffery-Giraud, S., Béroud, C., Leturcq, F., Yaou, R. B., Hamroun, D., Michel-Calemard, L., Moizard, M.-P., Bernard, R., Cossée, M., Boisseau, P., et al. (2009) · Human Mutation · doi:10.1002/humu.20976 · Cited by 377
Sharp, N. J. H., Kornegay, J. N., Van Camp, S. D., Herbstreith, M. H., Secore, S. L., Kettle, S., Hung, W.-Y., Constantinou, C. D., Dykstra, M. J., Roses, A. D., et al. (1992) · Genomics · doi:10.1016/0888-7543(92)90210-j · Cited by 362
Dystrophin abnormalities in Duchenne/Becker muscular dystrophy
Hoffman, E. P., & Kunkel, L. M. (1989) · Neuron · doi:10.1016/0896-6273(89)90226-2 · Cited by 331
Chamberlain, J. S., Metzger, J., Reyes, M., Townsend, D., & Faulkner, J. A. (2007) · The FASEB Journal · doi:10.1096/fj.06-7353com · Cited by 330
Dystrophin, its interactions with other proteins, and implications for muscular dystrophy
Ervasti, J. M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.010 · Cited by 324
Flanigan, K. M., Dunn, D. M., von Niederhausern, A., Soltanzadeh, P., Gappmaier, E., Howard, M. T., Sampson, J. B., Mendell, J. R., Wall, C., King, W. M., et al. (2009) · Human Mutation · doi:10.1002/humu.21114 · Cited by 321
Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies
Grady, R. M., Grange, R. W., Lau, K. S., Maimone, M. M., Nichol, M. C., Stull, J. T., & Sanes, J. R. (1999) · Nature Cell Biology · doi:10.1038/12034 · Cited by 314
Brain function in Duchenne muscular dystrophy
Anderson, J. L., Head, S. I., Rae, C., & Morley, J. W. (2002) · Brain · doi:10.1093/brain/awf012 · Cited by 313
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice
Gregorevic, P., Allen, J. M., Minami, E., Blankinship, M. J., Haraguchi, M., Meuse, L., Finn, E., Adams, M. E., Froehner, S. C., Murry, C. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1439 · Cited by 307
Force and power output of fast and slow skeletal muscles from mdx mice 6‐28 months old
Lynch, G. S., Hinkle, R. T., Chamberlain, J. S., Brooks, S. V., & Faulkner, J. A. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00591.x · Cited by 306
Mcdonald, C. M., Henricson, E. K., Abresch, R. T., Florence, J. M., Eagle, M., Gappmaier, E., Glanzman, A. M., PTC124‐GD‐007‐DMD Study Group, Spiegel, R., Barth, J., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23902 · Cited by 303
Mechanical function of dystrophin in muscle cells.
Pasternak, C., Wong, S., & Elson, E. L. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.3.355 · Cited by 292
Improved diagnosis of Becker muscular dystrophy by dystrophin testing
Hoffman, E. P., Kunkel, L. M., Angelini, C., Clarke, A., Johnson, M., & Harris, J. B. (1989) · Neurology · doi:10.1212/wnl.39.8.1011 · Cited by 291
Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice
Phelps, S. F., Hauser, M. A., Cole, N. M., Rafael, J. A., Hinkle, R. T., Faulkner, J. A., & Chamberlain, J. S. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.8.1251 · Cited by 288
Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity
Cox, G. A., Cole, N. M., Matsumura, K., Phelps, S. F., Hauschka, S. D., Campbell, K. P., Faulkner, J. A., & Chamberlain, J. S. (1993) · Nature · doi:10.1038/364725a0 · Cited by 283
Uniquely human evolution of sialic acid genetics and biology
Varki, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914634107 · Cited by 278
Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan.
Huang, X., Poy, F., Zhang, R., Joachimiak, A., Sudol, M., & Eck, M. J. (2000) · Nature Structural Biology · doi:10.1038/77923 · Cited by 276
Burkin, D. J., Wallace, G. Q., Nicol, K. J., Kaufman, D. J., & Kaufman, S. J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1207 · Cited by 273
Dunckley, M. G., Manoharan, M., Villiet, P., Eperon, I. C., & Dickson, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1083 · Cited by 255
Deconinck, N., Tinsley, J., Backer, F. D., Fisher, R., Kahn, D., Phelps, S., Davies, K., & Gillis, J.-M. (1997) · Nature Medicine · doi:10.1038/nm1197-1216 · Cited by 250
A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
Mendell, J. R., Sahenk, Z., Malik, V., Gomez, A. M., Flanigan, K. M., Lowes, L. P., Alfano, L. N., Berry, K., Meadows, E., Lewis, S., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2014.200 · Cited by 246
Jearawiriyapaisarn, N., Moulton, H. M., Buckley, B., Roberts, J., Sazani, P., Fucharoen, S., Iversen, P. L., & Kole, R. (2008) · Molecular Therapy · doi:10.1038/mt.2008.120 · Cited by 244
Canine X-linked muscular dystrophy
Valentine, B. A., Cooper, B. J., de Lahunta, A., O'Quinn, R., & Blue, J. T. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90206-7 · Cited by 242
Muscular dystrophy in a litter of golden retriever dogs
Kornegay, J. N., Tuler, S. M., Miller, D. M., & Levesque, D. C. (1988) · Muscle & Nerve · doi:10.1002/mus.880111008 · Cited by 239
Wu, B., Moulton, H. M., Iversen, P. L., Jiang, J., Li, J., Li, J., Spurney, C. F., Sali, A., Guerron, A. D., Nagaraju, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805676105 · Cited by 236
Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice.
Chapman, V. M., Miller, D. R., Armstrong, D., & Caskey, C. T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1292 · Cited by 229
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors
Lai, Y., Yue, Y., Liu, M., Ghosh, A., Engelhardt, J. F., Chamberlain, J. S., & Duan, D. (2005) · Nature Biotechnology · doi:10.1038/nbt1153 · Cited by 224
Self-citationYin, H., Moulton, H. M., Seow, Y., Boyd, C., Boutilier, J., Iverson, P., & Wood, M. J. A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn293 · Cited by 224
Crawford, G. E., Faulkner, J. A., Crosbie, R. H., Campbell, K. P., Froehner, S. C., & Chamberlain, J. S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.6.1399 · Cited by 222
Wang, Z., Kuhr, C. S., Allen, J. M., Blankinship, M., Gregorevic, P., Chamberlain, J. S., Tapscott, S. J., & Storb, R. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300161 · Cited by 218
Differential expression of dystrophin isoforms in strains of mdx mice with different mutations
Im, W. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.8.1149 · Cited by 212
Taylor, P. J., Betts, G. A., Maroulis, S., Gilissen, C., Pedersen, R. L., Mowat, D. R., Johnston, H. M., & Buckley, M. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008803 · Cited by 208
Henricson, E. K., Abresch, R. T., Cnaan, A., Hu, F., Duong, T., Arrieta, A., Han, J., Escolar, D. M., Florence, J. M., Clemens, P. R., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23808 · Cited by 208
McClorey, G., Moulton, H. M., Iversen, P. L., Fletcher, S., & Wilton, S. D. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302800 · Cited by 207
Genetic Background Affects Properties of Satellite Cells and mdx Phenotypes
Fukada, S.-I., Morikawa, D., Yamamoto, Y., Yoshida, T., Sumie, N., Yamaguchi, M., Ito, T., Miyagoe-Suzuki, Y., Takeda, S., Tsujikawa, K., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090887 · Cited by 207
Rafael, J. A., Tinsley, J. M., Potter, A. C., Deconinck, A. E., & Davies, K. E. (1998) · Nature Genetics · doi:10.1038/ng0598-79 · Cited by 203
Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy
Mendell, J. R., & Lloyd‐Puryear, M. (2013) · Muscle & Nerve · doi:10.1002/mus.23810 · Cited by 202
Age-related changes in the proportion of types I and III collagen
MAYS, P., BISHOP, J., & LAURENT, G. (1988) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(88)90002-4 · Cited by 201
Phenotype of dystrophinopathy in old MDX mice
Lefaucheur, J. P., Pastoret, C., & Sebille, A. (1995) · The Anatomical Record · doi:10.1002/ar.1092420109 · Cited by 199
N-Glycolylneuraminic Acid Deficiency in Mice: Implications for Human Biology and Evolution
Hedlund, M., Tangvoranuntakul, P., Takematsu, H., Long, J. M., Housley, G. D., Kozutsumi, Y., Suzuki, A., Wynshaw-Boris, A., Ryan, A. F., Gallo, R. L., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00379-07 · Cited by 196
Selsby, J. T., Morine, K. J., Pendrak, K., Barton, E. R., & Sweeney, H. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030063 · Cited by 195
Desguerre, I., Christov, C., Mayer, M., Zeller, R., Becane, H.-M., Bastuji-Garin, S., Leturcq, F., Chiron, C., Chelly, J., & Gherardi, R. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004347 · Cited by 195
Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children
Decary, S., Ben Hamida, C., Mouly, V., Barbet, J. P., Hentati, F., & Butler-Browne, G. S. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00093-0 · Cited by 195
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
Rodino‐Klapac, L. R., Haidet, A. M., Kota, J., Handy, C., Kaspar, B. K., & Mendell, J. R. (2009) · Muscle & Nerve · doi:10.1002/mus.21244 · Cited by 194
Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle
Gebski, B. L., Mann, C. J., Fletcher, S., & Wilton, S. D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg196 · Cited by 194
New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin
Cox, G. A., Phelps, S. F., Chapman, V. M., & Chamberlain, J. S. (1993) · Nature Genetics · doi:10.1038/ng0593-87 · Cited by 192
Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up
Magri, F., Govoni, A., D’Angelo, M. G., Del Bo, R., Ghezzi, S., Sandra, G., Turconi, A. C., Sciacco, M., Ciscato, P., Bordoni, A., et al. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5979-z · Cited by 189
Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: A review
Snow, W. M., Anderson, J. E., & Jakobson, L. S. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.016 · Cited by 189
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
Kornegay, J. N., Bogan, J. R., Bogan, D. J., Childers, M. K., Li, J., Nghiem, P., Detwiler, D. A., Larsen, C. A., Grange, R. W., Bhavaraju-Sanka, R. K., et al. (2012) · Mammalian Genome · doi:10.1007/s00335-011-9382-y · Cited by 186
McDonald, C. M., Henricson, E. K., Abresch, R. T., Han, J. J., Escolar, D. M., Florence, J. M., Duong, T., Arrieta, A., Clemens, P. R., Hoffman, E. P., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23807 · Cited by 183
Ousterout, D. G., Perez-Pinera, P., Thakore, P. I., Kabadi, A. M., Brown, M. T., Qin, X., Fedrigo, O., Mouly, V., Tremblay, J. P., & Gersbach, C. A. (2013) · Molecular Therapy · doi:10.1038/mt.2013.111 · Cited by 181
Bostick, B., Ghosh, A., Yue, Y., Long, C., & Duan, D. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303029 · Cited by 180
Self-citationPane, M., Lombardo, M. E., Alfieri, P., D'Amico, A., Bianco, F., Vasco, G., Piccini, G., Mallardi, M., Romeo, D. M., Ricotti, V., et al. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.03.020 · Cited by 178
Liu, M., Yue, Y., Harper, S. Q., Grange, R. W., Chamberlain, J. S., & Duan, D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.013 · Cited by 178
Self-citationSekiguchi, M., Zushida, K., Yoshida, M., Maekawa, M., Kamichi, S., Yoshida, M., Sahara, Y., Yuasa, S., Takeda, S., & Wada, K. (2008) · Brain · doi:10.1093/brain/awn253 · Cited by 177
Generation of muscular dystrophy model rats with a CRISPR/Cas system
Nakamura, K., Fujii, W., Tsuboi, M., Tanihata, J., Teramoto, N., Takeuchi, S., Naito, K., Yamanouchi, K., & Nishihara, M. (2014) · Scientific Reports · doi:10.1038/srep05635 · Cited by 175
Klymiuk, N., Blutke, A., Graf, A., Krause, S., Burkhardt, K., Wuensch, A., Krebs, S., Kessler, B., Zakhartchenko, V., Kurome, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt287 · Cited by 175
Kumar-Singh, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.913 · Cited by 175
Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human
Neri, M., Torelli, S., Brown, S., Ugo, I., Sabatelli, P., Merlini, L., Spitali, P., Rimessi, P., Gualandi, F., Sewry, C., et al. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.07.005 · Cited by 173
Yue, Y., Ghosh, A., Long, C., Bostick, B., Smith, B. F., Kornegay, J. N., & Duan, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.207 · Cited by 173
Self-citationThe 6‐minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observations
MCDonald, C. M., Henricson, E. K., Han, J. J., Abresch, R. T., Nicorici, A., Atkinson, L., Elfring, G. L., Reha, A., & Miller, L. L. (2010) · Muscle & Nerve · doi:10.1002/mus.21808 · Cited by 172
Cox, G. A., Sunada, Y., Campbell, K. P., & Chamberlain, J. S. (1994) · Nature Genetics · doi:10.1038/ng1294-333 · Cited by 171
DelloRusso, C., Scott, J. M., Hartigan-O’Connor, D. J., Salvatori, G., Barjot, C., Robinson, A. S., Crawford, R. W., Brooks, S. V., & Chamberlain, J. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202300099 · Cited by 170
Vaillend, C., Billard, J.-M., & Laroche, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.05.004 · Cited by 169
Bencze, M., Négroni, E., Vallese, D., Yacoub‐Youssef, H., Chaouch, S., Wolff, A., Aamiri, A., Santo, J. P. D., Chazaud, B., Butler-Browne, G. S., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.189 · Cited by 165
Dystrophin is a tumor suppressor in human cancers with myogenic programs
Wang, Y., Marino-Enriquez, A., Bennett, R. R., Zhu, M., Shen, Y., Eilers, G., Lee, J.-C., Henze, J., Fletcher, B. S., Gu, Z., et al. (2014) · Nature Genetics · doi:10.1038/ng.2974 · Cited by 163
Gene therapy of muscular dystrophy
Chamberlain, J. S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2355 · Cited by 162
Ghosh, A., Yue, Y., Lai, Y., & Duan, D. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300322 · Cited by 161
Self-citationMuscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping
Vulin, A., Barthélémy, I., Goyenvalle, A., Thibaud, J. L., Beley, C., Griffith, G., Benchaouir, R., Hir, M. L., Unterfinger, Y., Lorain, S., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.181 · Cited by 161
Bodywide skipping of exons 45–55 in dystrophic mdx52 mice by systemic antisense delivery
Aoki, Y., Yokota, T., Nagata, T., Nakamura, A., Tanihata, J., Saito, T., Duguez, S. M. R., Nagaraju, K., Hoffman, E. P., Partridge, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204638109 · Cited by 160
Flightless flies: Drosophila models of neuromuscular disease
Lloyd, T. E., & Taylor, J. P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05432.x · Cited by 160
Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides
Rando, T. A., Disatnik, M.-H., & Zhou, L. Z.-H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5363 · Cited by 160
Bushby, K., & Connor, E. (2011) · Clinical Investigation · doi:10.4155/cli.11.113 · Cited by 159
Kornegay, J. N., Li, J., Bogan, J. R., Bogan, D. J., Chen, C., Zheng, H., Wang, B., Qiao, C., Howard, J. F., & Xiao, X. (2010) · Molecular Therapy · doi:10.1038/mt.2010.94 · Cited by 158
Wu, B., Li, Y., Morcos, P. A., Doran, T. J., Lu, P., & Lu, Q. L. (2009) · Molecular Therapy · doi:10.1038/mt.2009.38 · Cited by 158
Stephenson, D. G., Lamb, G. D., & Stephenson, G. M. M. (1998) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1998.0304f.x · Cited by 158
Bartlett, R. J., Stockinger, S., Denis, M. M., Bartlett, W. T., Inverardi, L., Le, T. T., Mân, N. T., Morris, G. E., Bogan, D. J., Bogan, J. R., et al. (2000) · Nature Biotechnology · doi:10.1038/76448 · Cited by 156
Wells, D. J., Wells, K. E., Asante, E. A., Turner, G., Sunada, Y., Campbell, K. P., Walsh, F. S., & Dickson, G. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.8.1245 · Cited by 155
Severe muscular dystrophy in mice that lack dystrophin and α7 integrin
Rooney, J. E., Welser, J. V., Dechert, M. A., Flintoff‐Dye, N. L., Kaufman, S. J., & Burkin, D. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.02952 · Cited by 155
Yue, Y., Li, Z., Harper, S. Q., Davisson, R. L., Chamberlain, J. S., & Duan, D. (2003) · Circulation · doi:10.1161/01.cir.0000089371.11664.27 · Cited by 149
Self-citationRole of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
Mourkioti, F., Kustan, J., Kraft, P. E., Day, J., Zhao, M., Kost‐Alimova, M., Protopopov, A. I., DePinho, R. A., Bernstein, D., Meeker, A. K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2790 · Cited by 146
Haecker, S. E., Stedman, H. H., Balice‐Gordon, R. J., Smith, D. B. J., Greelish, J. P., Mitchell, M. A., Wells, A. L., Sweeney, H. L., & Wilson, J. M. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.15-1907 · Cited by 146
Microdystrophin Ameliorates Muscular Dystrophy in the Canine Model of Duchenne Muscular Dystrophy
Shin, J., Pan, X., Hakim, C. H., Yang, H. T., Yue, Y., Zhang, K., Terjung, R. L., & Duan, D. (2013) · Molecular Therapy · doi:10.1038/mt.2012.283 · Cited by 146
Self-citationGailly, P. L. (2002) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(02)00442-9 · Cited by 146
Daoud, F., Candelario‐Martínez, A., Billard, J., Avital, A., Khelfaoui, M., Rozenvald, Y., Guégan, M., Mornet, D., Jaillard, D., Nudel, U., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006574 · Cited by 146
The Frequency of Revertants in mdx Mouse Genetic Models for Duchenne Muscular Dystrophy
Dankó, I., Chapman, V. M., & Wolff, J. A. (1992) · Pediatric Research · doi:10.1203/00006450-199207000-00025 · Cited by 144
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model
Denti, M. A., Rosa, A., D’Antona, G., Sthandier, O., Angelis, F. G. D., Nicoletti, C., Allocca, M., Pansarasa, O., Parente, V., Musarò, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508917103 · Cited by 142
Adenovirus-Mediated Utrophin Gene Transfer Mitigates the Dystrophic Phenotype of mdx Mouse Muscles
Gilbert, R., Nalbantoglu, J. N., Petrof, B. J., Ebihara, S., Guibinga, G.-H., Tinsley, J. M., Kamen, A., Massie, B., Davies, K. E., & Karpati, G. (1999) · Human Gene Therapy · doi:10.1089/10430349950017987 · Cited by 141
Walmsley, G., Arechavala‐Gomeza, V., Fernández-Fuente, M., Burke, M. M., Nagel, N., Holder, A. L., Stanley, R. L., Chandler, K., Marks, S. L., Muntoni, F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008647 · Cited by 141
Gosselin, L. E., Adams, C., Cotter, T., McCormick, R. J., & Thomas, D. P. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.3.1011 · Cited by 138
Rafael‐Fortney, J. A., Chimanji, N. S., Schill, K. E., Martin, C. D., Murray, J. D., Ganguly, R., Stangland, J. E., Tran, T., Xu, Y., Canan, B. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.031716 · Cited by 138
Guiner, C. L., Montus, M., Servais, L., Chérel, Y., François, V., Thibaud, J. L., Wary, C., Matot, B., Larcher, T., Guigand, L., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.151 · Cited by 137
Yin, H., Saleh, A. F. A., Betts, C., Camelliti, P., Seow, Y., Ashraf, S., Arzumanov, A. A., Hammond, S. M., Merritt, T. M., Gait, M. J., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.79 · Cited by 135
Townsend, D., Blankinship, M. J., Allen, J. M., Gregorevic, P., Chamberlain, J. S., & Metzger, J. M. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300144 · Cited by 135
Lynch, G. S., Rafael, J. A., Chamberlain, J. S., & Faulkner, J. A. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.4.c1290 · Cited by 133
Splice Modulating Therapies for Human Disease
Spitali, P., & Aartsma-Rus, A. M. (2012) · Cell · doi:10.1016/j.cell.2012.02.014 · Cited by 130
Wein, N., Vulin, A., Falzarano, M. S., Szigyarto, C. A., Maiti, B., Findlay, A. R., Heller, K. N., Uhlén, M., Bakthavachalu, B., Messina, S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3628 · Cited by 129
Greenberg, D., Sunada, Y., Campbell, K. P., Yaffe, D., & Nudel, U. (1994) · Nature Genetics · doi:10.1038/ng1294-340 · Cited by 129
Severe cardiomyopathy in mice lacking dystrophin and MyoD
Megeney, L. A., Kablar, B., Perry, R. L., Ying, C., May, L. L., & Rudnicki, M. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.220 · Cited by 129
Canine X‐linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: A review
Valentine, B. A., Winand, N. J., Pradhan, D., Möise, N. S., de Lahunta, A., Kornegay, J. N., & Cooper, B. J. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320420320 · Cited by 128
Canine X-linked muscular dystrophy: Morphologic lesions
Valentine, B. A., Cooper, B. J., Cummings, J. F., & de Lahunta, A. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90095-5 · Cited by 128
Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex
Judge, L. M., Haraguchiln, M., & Chamberlain, J. S. (2006) · Journal of Cell Science · doi:10.1242/jcs.02857 · Cited by 128
Canine and feline models of human inherited muscle diseases
Shelton, G. D., & Engvall, E. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.10.019 · Cited by 127
Therapeutic approaches to muscular dystrophy
Goyenvalle, A., Seto, J. T., Davies, K. E., & Chamberlain, J. S. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr105 · Cited by 127
Cerletti, M., Negri, T., Cozzi, F., Colpo, R., Andreetta, F., Croci, D., Davies, K. E., Cornelio, F., Pozza, O., Karpati, G., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301941 · Cited by 126
Chandrasekharan, K., Yoon, J. H., Xu, Y., deVries, S., Camboni, M., Janssen, P. M. L., Varki, A. P., & Martin, P. T. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000692 · Cited by 126
Odom, G. L., Gregorevic, P., Allen, J. M., Finn, E. E., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.149 · Cited by 125
Canine X-Linked Muscular Dystrophy in Japan (CXMDJ).
Shimatsu, Y., KATAGIRI, K., FURUTA, T., Nakura, M., Tanioka, Y., Yuasa, K., Tomohiro, M., Kornegay, J. N., Nonaka, I., & Takeda, S. (2003) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.52.93 · Cited by 125
T-Cell-Dependent Fibrosis in the mdx Dystrophic Mouse
Morrison, J. I., Lu, Q. L., Pastoret, C., Partridge, T. A., & Bou–Gharios, G. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780092 · Cited by 125
Gene therapy for muscular dystrophy: Lessons learned and path forward
Mendell, J. R., Rodino‐Klapac, L. R., Sahenk, Z., Malik, V., Kaspar, B. K., Walker, C. M., & Clark, K. R. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.04.078 · Cited by 124
Muscle Lesions Associated with Dystrophin Deficiency in Neonatal Golden Retriever Puppies
Nguyen, F., Chérel, Y., Guigand, L., Goubault-Leroux, I., & Wyers, M. (2002) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0526 · Cited by 123
Viidik, A. (1968) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1968.tb04245.x · Cited by 120
Bostick, B., Yue, Y., Long, C., & Duan, D. (2007) · Circulation Research · doi:10.1161/circresaha.107.162982 · Cited by 120
Self-citationThe Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
van Putten, M., Hulsker, M., Nadarajah, V. D., van Heiningen, S. H., van Huizen, E., van Iterson, M., Admiraal, P. J. J., Messemaker, T. C., den Dunnen, J. T., Hoen, P. A. C. ’., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031937 · Cited by 120
Gregorevic, P., Blankinship, M. J., Allen, J. M., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.28 · Cited by 120
Foster, H., Sharp, P. S., Athanasopoulos, T., Trollet, C., Graham, I. R., Foster, K., Wells, D. J., & Dickson, G. (2008) · Molecular Therapy · doi:10.1038/mt.2008.186 · Cited by 119
Ousterout, D. G., Kabadi, A. M., Thakore, P. I., Pérez‐Piñera, P., Brown, M. T., Majoros, W. H., Reddy, T. E., & Gersbach, C. A. (2014) · Molecular Therapy · doi:10.1038/mt.2014.234 · Cited by 119
Moizard, M., Billard, C., Toutain, A., Berret, F., Marmin, N., & Moraine, C. (1998) · American Journal of Medical Genetics · Cited by 119
Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo
Dunckley, M. G., Wells, D. J., Walsh, F. S., & Dickson, G. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.6.717 · Cited by 119
PAI-1–regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy
Ardite, E., Perdiguero, E., Vidal, B., Gutarra, S., Serrano, A. L., & Muñoz‐Cánoves, P. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201105013 · Cited by 119
Yoshimura, M., Sakamoto, M., Ikemoto‐Uezumi, M., Mochizuki, Y., Yuasa, K., Miyagoe‐Suzuki, Y., & Takeda, S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.025 · Cited by 118
Emergent Dilated Cardiomyopathy Caused by Targeted Repair of Dystrophic Skeletal Muscle
Townsend, D., Yasuda, S., Li, S., Chamberlain, J. S., & Metzger, J. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.52 · Cited by 118
Moizard, M., Toutain, A., Fournier, D., Berret, F., Raynaud, M., Billard, C., Andres, C. R., & Moraine, C. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200488 · Cited by 118
Molecular analysis of a spontaneous dystrophin `knockout' dog
Schatzberg, S. J., Olby, N. J., Breen, M., Anderson, L. V. B., Langford, C. F., Dickens, H. F., Wilton, S. D., Zeiss, C. J., Binns, M. M., Kornegay, J. N., et al. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00011-5 · Cited by 117
Sarig, R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.1 · Cited by 116
van Putten, M., Hulsker, M., Young, C. S., Nadarajah, V. D., Heemskerk, H., van der Weerd, L., Hoen, P. A. C. ’., van Ommen, G. B., & Aartsma-Rus, A. M. (2013) · The FASEB Journal · doi:10.1096/fj.12-224170 · Cited by 115
Burkin, D. J., Wallace, G. Q., Milner, D. J., Chaney, E. J., Mulligan, J. A., & Kaufman, S. J. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62249-3 · Cited by 114
Goyenvalle, A., Babbs, A., Wright, J., Wilkins, V., Powell, D., García, L., & Davies, K. E. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds082 · Cited by 114
Guo, C., Willem, M., Werner, A., Raivich, G., Emerson, M., Neyses, L., & Mayer, U. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl018 · Cited by 114
Arpke, R. W., Darabi, R., Mader, T. L., Zhang, Y., Toyama, A., Lonetree, C.-L., Nash, N. L., Lowe, D. A., Perlingeiro, R. C. R., & Kyba, M. (2013) · Stem Cells · doi:10.1002/stem.1402 · Cited by 113
Vaillend, C., Rendon, A., Misslin, R., & Ungerer, A. (1995) · Behavior Genetics · doi:10.1007/bf02327580 · Cited by 112
The Status of Exon Skipping as a Therapeutic Approach to Duchenne Muscular Dystrophy
Lu, Q., Yokota, T., Takeda, S., García, L., Muntoni, F., & Partridge, T. A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.219 · Cited by 111
Yuasa, K., Yoshimura, M., Urasawa, N., Ohshima, S., Howell, J. M., Nakamura, A., Hijikata, T., Miyagoe‐Suzuki, Y., & Takeda, S. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302984 · Cited by 111
Dystrophin in the Nervous System
Lidov, H. G. W. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00783.x · Cited by 110
Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin‐null mice
Li, D., Yue, Y., Lai, Y., Hakim, C. H., & Duan, D. (2010) · The Journal of Pathology · doi:10.1002/path.2799 · Cited by 110
Self-citationFarini, A., Meregalli, M., Belicchi, M., Battistelli, M., Parolini, D., D’Antona, G., Gavina, M., Ottoboni, L., Constantin, G., Bottinelli, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2213 · Cited by 110
Characteristics of Skeletal Muscle in Mdx Mutant Mice
de la Porte, S., Morin, S., & Koenig, J. (1999) · International review of cytology · doi:10.1016/s0074-7696(08)60158-8 · Cited by 109
Cognitive impairment in neuromuscular disorders
D’Angelo, M. G., & Bresolin, N. (2006) · Muscle & Nerve · doi:10.1002/mus.20535 · Cited by 106
Koo, T., Popplewell, L., Athanasopoulos, T., & Dickson, G. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.164 · Cited by 104
Passive avoidance behaviour deficit in the mdx mouse
Francesco Muntoni, A., Mateddu, A., & Serra, G. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90059-2 · Cited by 101
Functional muscle ischemia in Duchenne and Becker muscular dystrophy
Thomas, G. D. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00381 · Cited by 101
Spurney, C. F., Shimizu, R., Morgenroth, L. P., Kolski, H., Gordish‐Dressman, H., Clemens, P. R., & the CINRG Investigators (2014) · Muscle & Nerve · doi:10.1002/mus.24163 · Cited by 101
Bostick, B., Yue, Y., Lai, Y., Long, C., Li, D., & Duan, D. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.058 · Cited by 100
Self-citationBostick, B., Yue, Y., Long, C., Marschalk, N., Fine, D. M., Chen, J., & Duan, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.264 · Cited by 100
Self-citationIncreased Serum Alanine Aminotransferase Activity Associated With Muscle Necrosis in the Dog
Valentine, B. A., Blue, J. T., Shelley, S. M., & Cooper, B. J. (1990) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1990.tb00886.x · Cited by 96
Gene Therapy of mdx Mice With Large Truncated Dystrophins Generated by Recombination Using rAAV6
Odom, G. L., Gregorevic, P., Allen, J. M., & Chamberlain, J. S. (2011) · Molecular Therapy · doi:10.1038/mt.2010.205 · Cited by 95
Zhang, Y., & Duan, D. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.131 · Cited by 95
Self-citationNicholson, L. V. B., Johnson, M. A., Bushby, K. M. D., Gardner‐Medwin, D., Curtis, A., Ginjaar, I. B., den Dunnen, J. T., Welch, J. L., Butler, T. J., & Bakker, E. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.9.728 · Cited by 95
Cited by
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
Duan, D. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.011 · Cited by 489
Self-citationSkeletal muscle fibrosis: an overview
Mahdy, M. A. A. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-2955-2 · Cited by 363
Comparative transcriptomics in human and mouse
Breschi, A., Gingeras, T. R., & Guigó, R. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.19 · Cited by 360
GPR41 and GPR43 in Obesity and Inflammation – Protective or Causative?
Ang, Z., & Ding, J. L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00028 · Cited by 304
The Pathogenesis and Therapy of Muscular Dystrophies
Guiraud, S., Aartsma-Rus, A., Vieira, N. M., Davies, K. E., van Ommen, G.-J. B., & Kunkel, L. M. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-025003 · Cited by 302
Metadata
- Authors
- McGreevy, J. W., Hakim, C. H., McIntosh, M. A., & Duan, D.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2015-03-01
- Volume
- 8
- Issue
- 3
- Pages
- 195-213
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2097136884
- Cited by
- 512
- References
- 332
- FWCI
- 17.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.